Eaton Vance Tax-Managed Global Dividend Income Fund

TWO INTERNATIONAL PLACE,
BOSTON , MA, 02110

Rank

Rank Universe
92 90

Summary

The fund seeks to invest appreciate capital through investing in stocks around the world that pay dividend that qualify for long term capital gains federal taxation.

The fund primarily invests in foreign companies based in the developed regions of the world with a track record of dividend payment that are tax-favored. In addition, these companies are estimated to be undervalued compared to other opportunities. The manager also looks More

Link

Directors

Jan 10, 2024
  • Cynthia E. Frost
  • Anchal Pachnanda
  • Scott E. Wennerholm
  • George J. Gorman
  • Alan C. Bowser
  • Mark R. Fetting
  • Nancy A. Wiser
  • Keith Quinton
  • Valerie A. Mosley
  • Susan J. Sutherland
  • Marcus L. Smith

Chief Compliance Officer

  • Richard F. Froio

Fund Manager(s)

  • John Croft
  • Christopher Dyer
  • Derek DiGregorio

Price

  • $ 16.66 ( -0.03 )
    Dec 31, 2024
    Last Close
  • Net Assets
  • $603.4M
    Mar 28, 2024
  • Holding
  • 41
    Sep 27, 2024
    More

  • 52-Week High/Low
  • $17.83 - $15.66
  • Turnover
  • 37.4%
  • Expense Ratio
  • 0.95%

Company Name

Holding

Novo Nordisk A/S 3.38 %
ASML Holding NV 2.66 %
EOG Resources Inc 2.25 %
BT Group PLC 2.03 %
Enagas SA 1.61 %
Elevance Health Inc 1.26 %
Boston Scientific Corp 1.24 %
Wells Fargo & Co 1.23 %
Acciona SA 1.21 %
Micron Technology Inc 1.11 %
More 1.11 %

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

-3.53%

5 Year

22.5%

Best

25.29%

2019

Worst

-38.24%

2008

Alpha

EIDIX S&P 500

Chart +